Three Independent Studies Include the ImmuKnow(R) Assay to Manage and Optimize Immunosuppression Therapy in Transplant Patients
The results of these studies will be presented during the American Transplant Congress in Boston, MA May 30 - June 3, 2009
COLUMBIA, Md., May 31 /PRNewswire/ -- A study conducted at Westchester Medical Center in Valhalla, NY examined liver transplant recipients to determine whether the use o...
Behavioral Modification Programs Help Obese Children Manage Their Weight
ROCKVILLE, Md., Sept. 29 /PRNewswire-USNewswire/ -- Obese school-age
kids and teens can lose weight or prevent further weight gain if they
participate in medium- to high-intensity behavioral management programs,
according to a new report released today by HHS' Agency for Healthcare
Research an...
Side Effects of Sunitinib in Kidney Cancer Are 2 to 3 Times More Expensive to Manage Than Those of Avastin Plus Interferon
- Tolerability is an Increasingly Important Factor When Selecting Treatment Options for Patients - ABSTRACT No: 5110 (Poster 6H)
BASEL, Switzerland, May 30 /PRNewswire/ -- Data presented at the
largest oncology meeting in the world, the American Societ...
Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinson's Disease
Effort utilizes Phreesia's automated patient check-in system to enable better management of medication wear-off
NEW YORK, April 15 /PRNewswire/ -- Phreesia, Inc., the Patient Check-In
Company, has announced that it will integrate a new screening tool
developed by researchers at...
New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
SKILLMAN, N.J., Jan. 11 /PRNewswire/ -- According to the American
Academy of Dermatology (AAD), 10-20 percent of the world's population
suffers from eczema, an inflamed skin condition characterized by red, scaly
and itchy skin. To help
manage the condition's symptoms, which tend to
flare up in...
Lyrica Significantly Reduced Pain and Helped Patients Manage the
Symptoms of Fibromyalgia, Data Show
BOSTON--(BUSINESS WIRE)--May 1, 2007 - Significantly more patients
treated with Pfizer's Lyrica reduced their pain by 50 percent or
more compared with placebo, according to study results presented
today at the American Academy of Neurology annual meeting.
Clinically, this outcome would equate to a ...
SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite
...out of the entire OLSAS as per our plan for the India operations," said Dr. Ajit Nair, President, India Operations, SIRO Clinpharm. "This will help us
manage critical tasks in clinical operations and drug safety in an efficient and globally compliant manner, thus providing our clients the best of technology...
Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus
...ut how to prevent the spread of disease" ( http://cdc.gov/h1n1flu/college-alert.htm ). FairChoice Health will also allow campus health officers to
manage the administration of an H1N1 vaccine to students once it is available.
FairChoice Health is based on technology developed and in use at Columb...
FDA Advisory Committee Votes in Favor of SAPHRIS(R) (asenapine) for Acute Bipolar I Disorder and Acute Schizophrenia
...g metabolic side effects. Poor tolerability frequently leads to treatment discontinuation even when the treatment is providing some benefit. To help
manage this challenge, patients often receive multiple medications or need to switch treatments.
About Schering-Plough
Schering-Plough is an in...
European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK
...-based patient randomization, auto-coding and laboratory data import solutions in addition to its Electronic Data Capture (EDC) product to efficiently
manage the study.
"We are extremely delighted to have been awarded this important clinical project. It is very encouraging to see a Top 20 pharmaceut...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...Women who suffer from osteoporosis like me must be proactive about how they
manage their bone health before they break a bone. I encourage them to be more pr...health can be found through educating and empowering women to more actively
manage their disease, six leading women's advocacy groups have joined forces to cr...
S.C. Medical Home Pilot for Diabetes Enrolls 1,110
... eligible patients to explain the concept, to gather baseline health data, and to encourage them to use an online portal that contains tools that help
manage their disease and enable them to have "e-visits" with a physician.
The case managers aim to reduce gaps in care, such as missed appointments w...
NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
...SP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to
manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain...
CareFirst BCBS Covers eNO Measurement for Diagnosis, Asthma Treatment
...steroid (ICS) treatments. The authors stated that eNO is a valuable tool to
manage ICS and monitor its effects.
The American Thoracic Society is pr...termining the level of airway inflammation can help clinicians more closely
manage their patients' inflammatory condition and therefore more precisely titrate...
International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
...etect asbestos-related diseases and cancer at an earlier stage.
Earlier detection will allow the possibility for additional treatment options to
manage the pain caused by pleural plaque beyond the narcotics often prescribed for patients with advanced stages of asbestos disease. This includes exploring...
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease
...e Arizona's residents about Alzheimer's disease, research progress in the state and the resources needed to help patients, families, and professionals
manage the disease. The AAC is comprised of both the NIA-funded Arizona Disease Core Center (ADCC) and the state-funded Arizona Alzheimer's Research Center (...
University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
...ologies such as HPV DNA diagnostics and laboratory developed tests, reliance upon the collaborative efforts of other parties, the Company's ability to
manage its existing cash resources or raise additional cash resources, competition, intellectual property protection and intellectual property rights of othe...
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
... pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and
manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODE...
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
... University School of Medicine , USA and President of The
Epilepsy Therapy Project. "Epilepsy is a devastating condition that can be
very difficult to
manage and the availability of eslicarbazepine acetate adds
an important new choice of therapy for patients who are in vital need of
better seizure control."...
Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
...s the exclusive marketing and distribution rights to sodium oxybate for fibromyalgia in Europe and some other countries outside North America and will
manage registrations accordingly.
For further information
Contacts at Jazz Pharmaceuticals:
Willie Quinn, Executive Director, Corporate De...
Data Suggest Sodium Oxybate Significantly Improves Pain and the Core Symptoms of Fibromyalgia
...s the exclusive marketing and distribution rights to sodium oxybate for fibromyalgia in Europe and some other countries outside North America and will
manage registrations accordingly.
About Sodium Oxybate
Sodium oxybate is the sodium salt form of gamma-hydroxybutyrate, an endogenous neurotransmitt...
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
... Sciences Center at San Antonio. "No one questions for patients with stable angina, optimal medical therapy is important as one of the first steps to
manage disease. But for many patients, medical therapy is not enough, and revascularization may be a safe and effective option for improving their quality of...
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
...expected to enroll approximately 7,800 patients and potentially represents a targeted treatment option for the millions of patients who need to better
manage their weight. Arena has patents that cover lorcaserin in the US and other jurisdictions, which in most cases are capable of continuing into 2023 witho...
Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting
... reimbursement policies or adverse changes in those policies; any inability by the company to ship product on a timely basis; the company's ability to
manage its growth; adverse economic developments that could adversely affect the market for our products or our ability to raise needed financing; actions by...
NeurogesX Receives FDA Orphan Drug Designation for Qutenza(TM) for Treatment of Postherpetic Neuralgia
...SP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza, a dermal patch designed to
manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain...
Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions
...expected to enroll approximately 7,800 patients and potentially represents a targeted treatment option for the millions of patients who need to better
manage their weight. Arena has patents that cover lorcaserin in the US and other jurisdictions, which in most cases are capable of continuing into 2023 witho...
New Research Shows Antidepressants May Thwart Breast Cancer Treatment
...nt to tamoxifen and deserve to get the maximum benefit this medicine affords."
She pointed out that there are safe and effective alternatives to
manage depression and hot flashes that doctors can offer patients taking tamoxifen. Weiss advises women who have taken tamoxifen along with an antidepressant...
FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab)
...ls including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to
manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, th...
Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
...y's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business,
manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired business...
CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
...mong cancer patients. The campaign will provide resources and educational tools to help patients, families and healthcare providers better prevent and
manage treatment-related infections.
"Cancer patients undergoing chemotherapy are at a higher risk for infections, which can impact their treatment succ...
Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development
...evere forms of dysplasia and esophageal cancer. This and data from other recent trials may ultimately change the paradigm for how gastroenterologists
manage their patients with this disease."
As a result of chronic injury from gastroesophageal reflux disease (GERD), the normal esophageal lining is rep...
PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
...ications, PAREXEL continues to leverage our global footprint and ability to
manage complex programs on a worldwide scale to help biopharmaceutical companies a... certain industries and clients; the Company's ability to win new business,
manage growth and costs, and attract and retain employees; the Company's ability t...
Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
...lu outbreak, our system would enable a rapid response with the development of a strain-specific diagnostic test. This would help medical professionals
manage an outbreak more effectively from the outset."
SCR used its new system recently to quickly discover a DNA barcode for detecting the H1N1 Flu afte...
Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
...-on-hand to decline unexpectedly; (v) the timing difference between our receipt of contract milestone or scheduled payments and our incurring costs to
manage these trials; (vi) outsourcing trends in the pharmaceutical, biotechnology and medical device industries; (vii) the ability to maintain profit margins...
CVS Caremark Data Confirms Improved Outcomes for Women with Osteoporosis Who are Adherent to Therapy
...orosis and provide information about the treatments available today to help
manage osteoporosis and reduce the risk of fracture."
About CVS Caremark
...care services in the U.S. The Company is uniquely positioned to effectively
manage costs and improve health care outcomes through its more than 6,900 CVS/phar...
Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide
...re ), come at a time when attempts to intensively
manage glucose targets in the ICU setting have shown inco...tients receive the information necessary to safely
manage this aspect of their care once they are at home." ...he Association funds research to prevent, cure and
manage diabetes; delivers services to hundreds of communi...
Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
...n to hypertension, and to test whether this extensive subgrouping might provide additional insight for practicing physicians.
"It is essential to
manage blood pressure very aggressively in diabetics because their heart attack and stroke rates are more closely related to their blood pressure levels than...
Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
... of their cancer returning. For those patients whose GIST does return,
this can be devastating both physically and emotionally, even though Glivec
can
manage recurring GISTs. We hope that the future use of Glivec in the
adjuvant setting will help to reduce the risk of GIST recurrence and provide
reassurance...
FDA Approves Vanda Pharmaceuticals' Fanapt(TM) for the Treatment of Schizophrenia
...ntify or obtain rights to new products; Vanda's failure to develop or obtain sales, marketing and distribution resources and expertise or to otherwise
manage its growth; a loss of any of Vanda's key scientists or management personnel; losses incurred from product liability claims made against Vanda; a loss ...
AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
...ed about ARX-01; I believe it has the potential to address a large unmet medical need in the management of post-operative pain by allowing patients to
manage their pain without the need for an IV line or complicated IV PCA pumps. Seeing the smooth, uneventful initiation of this first study utilizing the AR...